The following is a listing of recent U.S. Food and Srug Administration (FDA) updates and activities:

• FDA Requires Guillain-Barré Syndrome (GBS) Warning in the Prescribing Information for RSV Vaccines Abrysvo and Arexvy: FDA Safety Communication

• FDA issues final guidance on communicating scientific information about unapproved uses

• FDA Issues Draft Guidance on Artificial Intelligence-Enabled Device Software Function

 

…

Sign Up for Free Trial

---

• Back
• MCN Blog